Literature DB >> 23422752

Evidence that fibrinogen γ' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans.

Marlien Pieters1, Retha C Kotze, Johann C Jerling, Annamarie Kruger, Robert A S Ariëns.   

Abstract

Fibrinogen γ' is known to influence fibrin clot structure in purified experimental models, but little is known regarding its influence on clot structure in plasma. Furthermore, the environmental and biological factors that affect its concentration are poorly described. We analyzed fibrinogen γ', total fibrinogen concentration, and fibrin clot structure in 2010 apparently healthy black South Africans and related them to traditional cardiovascular disease (CVD) risk factors. Fibrinogen γ' generally increased with increasing fibrinogen concentration, but a decreased γ'/total fibrinogen ratio was found at the highest total fibrinogen concentrations. Clot maximum absorbance increased with total fibrinogen and fibrinogen γ', but decreased with γ'/total fibrinogen ratio. Clot lysis time showed a stronger relationship with fibrinogen γ' than with total fibrinogen, whereby increased fibrinogen γ' delayed clot lysis. CVD risk factors (excluding fibrinogen) explained 20% and 3%, respectively, of the variance in fibrinogen γ' and the γ'/total fibrinogen ratio, with C-reactive protein making the biggest contribution. More than 50% of the variance in fibrinogen γ' and γ'/total fibrinogen ratio is explained by factors other than total fibrinogen or other traditional CVD risk factors. Our data show that fibrinogen γ' modulates plasma clot structure and fibrinolysis and is also influenced by factors other than fibrinogen.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23422752     DOI: 10.1182/blood-2012-12-471482

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.

Authors:  Paul Y Kim; Trang T Vu; Beverly A Leslie; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

2.  High fibrinogen γ' levels in patient plasma increase clot formation at arterial and venous shear.

Authors:  Fraser L Macrae; Frauke Swieringa; Johan W M Heemskerk; Robert A S Ariëns
Journal:  Blood Adv       Date:  2021-09-14

Review 3.  The role of fibrinogen in traumatic brain injury: from molecular pathological mechanisms to clinical management.

Authors:  Shixin Peng; Ke Lv
Journal:  Eur J Trauma Emerg Surg       Date:  2022-08-16       Impact factor: 2.374

4.  Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein.

Authors:  Konstanty Szułdrzyński; Miłosz Jankowski; Daniel P Potaczek; Anetta Undas
Journal:  Dis Markers       Date:  2020-01-25       Impact factor: 3.434

5.  The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice.

Authors:  B L Walton; T M Getz; W Bergmeier; F-C Lin; S Uitte de Willige; A S Wolberg
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

6.  γ' fibrinogen levels are associated with blood clot strength in traumatic brain injury patients.

Authors:  David H Farrell; Elizabeth A Rick; Elizabeth N Dewey; Martin A Schreiber; Susan E Rowell
Journal:  Am J Surg       Date:  2019-12-28       Impact factor: 2.565

7.  Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations.

Authors:  H Toinét Cronjé; Cornelie Nienaber-Rousseau; Lizelle Zandberg; Zelda de Lange; Fiona R Green; Marlien Pieters
Journal:  PLoS One       Date:  2017-11-03       Impact factor: 3.240

8.  Replication and expansion of epigenome-wide association literature in a black South African population.

Authors:  H Toinét Cronjé; Hannah R Elliott; Cornelie Nienaber-Rousseau; Marlien Pieters
Journal:  Clin Epigenetics       Date:  2020-01-07       Impact factor: 6.551

Review 9.  Fibrinogen and Atherosclerotic Cardiovascular Diseases-Review of the Literature and Clinical Studies.

Authors:  Stanisław Surma; Maciej Banach
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

10.  Lp(a) is not associated with diabetes but affects fibrinolysis and clot structure ex vivo.

Authors:  Marianne Månsson; Inge Kalies; Göran Bergström; Caroline Schmidt; Anne Legnehed; Lillemor Mattsson Hultén; Lena Amrot-Fors; David Gustafsson; Wolfgang Knecht
Journal:  Sci Rep       Date:  2014-06-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.